Stability of the LATS2 Tumor Suppressor Gene Is Regulated by Tristetraprolin
Open Access
- 1 June 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (23), 17329-17337
- https://doi.org/10.1074/jbc.m109.094235
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- miR-372 Regulates Cell Cycle and Apoptosis of AGS Human Gastric Cancer Cell Line through Direct Regulation of LATS2Molecules and Cells, 2009
- A role for transportin in deposition of TTP to cytoplasmic RNA granules and mRNA decayNucleic Acids Research, 2009
- The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient PrognosisCancer Research, 2009
- Tristetraprolin Inhibits Ras-dependent Tumor Vascularization by Inducing Vascular Endothelial Growth Factor mRNA DegradationMolecular Biology of the Cell, 2007
- Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profilesMolecular Cancer, 2007
- Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancersZeitschrift für Krebsforschung und Klinische Onkologie, 2007
- A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidizationGenes & Development, 2006
- LATS2–Ajuba complex regulates γ‐tubulin recruitment to centrosomes and spindle organization during mitosisFEBS Letters, 2006
- Inhibition of Cell Growth by Conditional Expression of kpm, a Human Homologue of Drosophila warts/lats Tumor SuppressorPublished by Elsevier ,2003
- Reversible cross-linking combined with immunoprecipitation to study RNA–protein interactions in vivoMethods, 2002